FRAX--Where are we now?

Area of Science:

• Osteoporosis and Bone Health
• Clinical Risk Assessment
• Pharmacoeconomics

Background:

• Bone mineral density (BMD) is a standard metric for osteoporosis diagnosis and fracture risk assessment.
• While BMD offers high specificity, its low sensitivity limits comprehensive fracture risk prediction.
• Clinical risk factors, independent of BMD, are crucial for improving fracture risk assessment.

Purpose of the Study:

• To review the strengths and limitations of the FRAX fracture risk algorithm.
• To evaluate the clinical utility of FRAX in osteoporosis management.
• To discuss the integration of FRAX with BMD in clinical practice.

Main Methods:

• Literature review of studies on BMD and fracture risk assessment.
• Analysis of the components and performance of the FRAX tool.
• Discussion of clinical case examples and guidelines.

Main Results:

• BMD measurements are specific but not sensitive for fracture prediction.
• FRAX algorithm integrates clinical risk factors to enhance fracture prediction accuracy.
• FRAX demonstrates utility in identifying high-risk individuals for intervention.

Conclusions:

• FRAX improves upon BMD alone for predicting fracture risk.
• The combination of BMD and FRAX offers a more comprehensive assessment.
• Understanding FRAX limitations is key for effective clinical application in osteoporosis.